0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet Antibiotic Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-14O12601
Home | Market Reports | Pets & Animals| Animal Products & Services| Pet Food & Supplies
Global Pet Antibiotic Market Research Report 2022
BUY CHAPTERS

Global Pet Antibiotic Market Research Report 2025

Code: QYRE-Auto-14O12601
Report
February 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet Antibiotic Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Pet Antibiotic Market

Pet Antibiotic Market

The global market for Pet Antibiotic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pet antibiotics are medications prescribed by veterinarians to treat bacterial infections in various types of pets, including dogs, cats, and other animals. These antibiotics are similar to those used in humans but are specifically formulated and dosed for animals. Just like humans, pets can develop bacterial infections that can lead to various health issues if left untreated. Pet antibiotics help combat these infections and promote the well-being of the animals.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 496%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Antibiotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Antibiotic.
The Pet Antibiotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Antibiotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Antibiotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pet Antibiotic Market Report

Report Metric Details
Report Name Pet Antibiotic Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
  • Oral
  • Injection
  • Others
Segment by Application
  • Dogs
  • Cats
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Elanco, Zoetis, Merck Animal Health, Merial, Bayer HealthCare, Boehringer Ingelheim GmbH, Ceva Santé Animale, Virbac Group, HealthforAnimals, Cymedica, Dechra, Jinhe Biotechnology, Orion Corporation, Phibro Animal Health Corporation, Vetoquinol, Virbac, Zydus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pet Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pet Antibiotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pet Antibiotic Market report?

Ans: The main players in the Pet Antibiotic Market are Elanco, Zoetis, Merck Animal Health, Merial, Bayer HealthCare, Boehringer Ingelheim GmbH, Ceva Santé Animale, Virbac Group, HealthforAnimals, Cymedica, Dechra, Jinhe Biotechnology, Orion Corporation, Phibro Animal Health Corporation, Vetoquinol, Virbac, Zydus

What are the Application segmentation covered in the Pet Antibiotic Market report?

Ans: The Applications covered in the Pet Antibiotic Market report are Dogs, Cats, Others

What are the Type segmentation covered in the Pet Antibiotic Market report?

Ans: The Types covered in the Pet Antibiotic Market report are Oral, Injection, Others

1 Pet Antibiotic Market Overview
1.1 Product Definition
1.2 Pet Antibiotic by Type
1.2.1 Global Pet Antibiotic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.2.4 Others
1.3 Pet Antibiotic by Application
1.3.1 Global Pet Antibiotic Market Value by Application (2024 VS 2031)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Others
1.4 Global Pet Antibiotic Market Size Estimates and Forecasts
1.4.1 Global Pet Antibiotic Revenue 2020-2031
1.4.2 Global Pet Antibiotic Sales 2020-2031
1.4.3 Global Pet Antibiotic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pet Antibiotic Market Competition by Manufacturers
2.1 Global Pet Antibiotic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pet Antibiotic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pet Antibiotic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pet Antibiotic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Antibiotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Antibiotic, Product Type & Application
2.7 Global Key Manufacturers of Pet Antibiotic, Date of Enter into This Industry
2.8 Global Pet Antibiotic Market Competitive Situation and Trends
2.8.1 Global Pet Antibiotic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pet Antibiotic Players Market Share by Revenue
2.8.3 Global Pet Antibiotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pet Antibiotic Market Scenario by Region
3.1 Global Pet Antibiotic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pet Antibiotic Sales by Region: 2020-2031
3.2.1 Global Pet Antibiotic Sales by Region: 2020-2025
3.2.2 Global Pet Antibiotic Sales by Region: 2026-2031
3.3 Global Pet Antibiotic Revenue by Region: 2020-2031
3.3.1 Global Pet Antibiotic Revenue by Region: 2020-2025
3.3.2 Global Pet Antibiotic Revenue by Region: 2026-2031
3.4 North America Pet Antibiotic Market Facts & Figures by Country
3.4.1 North America Pet Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pet Antibiotic Sales by Country (2020-2031)
3.4.3 North America Pet Antibiotic Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pet Antibiotic Market Facts & Figures by Country
3.5.1 Europe Pet Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pet Antibiotic Sales by Country (2020-2031)
3.5.3 Europe Pet Antibiotic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Antibiotic Market Facts & Figures by Region
3.6.1 Asia Pacific Pet Antibiotic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pet Antibiotic Sales by Region (2020-2031)
3.6.3 Asia Pacific Pet Antibiotic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pet Antibiotic Market Facts & Figures by Country
3.7.1 Latin America Pet Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pet Antibiotic Sales by Country (2020-2031)
3.7.3 Latin America Pet Antibiotic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Antibiotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Antibiotic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pet Antibiotic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pet Antibiotic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Antibiotic Sales by Type (2020-2031)
4.1.1 Global Pet Antibiotic Sales by Type (2020-2025)
4.1.2 Global Pet Antibiotic Sales by Type (2026-2031)
4.1.3 Global Pet Antibiotic Sales Market Share by Type (2020-2031)
4.2 Global Pet Antibiotic Revenue by Type (2020-2031)
4.2.1 Global Pet Antibiotic Revenue by Type (2020-2025)
4.2.2 Global Pet Antibiotic Revenue by Type (2026-2031)
4.2.3 Global Pet Antibiotic Revenue Market Share by Type (2020-2031)
4.3 Global Pet Antibiotic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pet Antibiotic Sales by Application (2020-2031)
5.1.1 Global Pet Antibiotic Sales by Application (2020-2025)
5.1.2 Global Pet Antibiotic Sales by Application (2026-2031)
5.1.3 Global Pet Antibiotic Sales Market Share by Application (2020-2031)
5.2 Global Pet Antibiotic Revenue by Application (2020-2031)
5.2.1 Global Pet Antibiotic Revenue by Application (2020-2025)
5.2.2 Global Pet Antibiotic Revenue by Application (2026-2031)
5.2.3 Global Pet Antibiotic Revenue Market Share by Application (2020-2031)
5.3 Global Pet Antibiotic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Elanco
6.1.1 Elanco Company Information
6.1.2 Elanco Description and Business Overview
6.1.3 Elanco Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Elanco Pet Antibiotic Product Portfolio
6.1.5 Elanco Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zoetis Pet Antibiotic Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck Animal Health
6.3.1 Merck Animal Health Company Information
6.3.2 Merck Animal Health Description and Business Overview
6.3.3 Merck Animal Health Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Animal Health Pet Antibiotic Product Portfolio
6.3.5 Merck Animal Health Recent Developments/Updates
6.4 Merial
6.4.1 Merial Company Information
6.4.2 Merial Description and Business Overview
6.4.3 Merial Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merial Pet Antibiotic Product Portfolio
6.4.5 Merial Recent Developments/Updates
6.5 Bayer HealthCare
6.5.1 Bayer HealthCare Company Information
6.5.2 Bayer HealthCare Description and Business Overview
6.5.3 Bayer HealthCare Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer HealthCare Pet Antibiotic Product Portfolio
6.5.5 Bayer HealthCare Recent Developments/Updates
6.6 Boehringer Ingelheim GmbH
6.6.1 Boehringer Ingelheim GmbH Company Information
6.6.2 Boehringer Ingelheim GmbH Description and Business Overview
6.6.3 Boehringer Ingelheim GmbH Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Ingelheim GmbH Pet Antibiotic Product Portfolio
6.6.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.7 Ceva Santé Animale
6.7.1 Ceva Santé Animale Company Information
6.7.2 Ceva Santé Animale Description and Business Overview
6.7.3 Ceva Santé Animale Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Santé Animale Pet Antibiotic Product Portfolio
6.7.5 Ceva Santé Animale Recent Developments/Updates
6.8 Virbac Group
6.8.1 Virbac Group Company Information
6.8.2 Virbac Group Description and Business Overview
6.8.3 Virbac Group Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Virbac Group Pet Antibiotic Product Portfolio
6.8.5 Virbac Group Recent Developments/Updates
6.9 HealthforAnimals
6.9.1 HealthforAnimals Company Information
6.9.2 HealthforAnimals Description and Business Overview
6.9.3 HealthforAnimals Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 HealthforAnimals Pet Antibiotic Product Portfolio
6.9.5 HealthforAnimals Recent Developments/Updates
6.10 Cymedica
6.10.1 Cymedica Company Information
6.10.2 Cymedica Description and Business Overview
6.10.3 Cymedica Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cymedica Pet Antibiotic Product Portfolio
6.10.5 Cymedica Recent Developments/Updates
6.11 Dechra
6.11.1 Dechra Company Information
6.11.2 Dechra Description and Business Overview
6.11.3 Dechra Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Dechra Pet Antibiotic Product Portfolio
6.11.5 Dechra Recent Developments/Updates
6.12 Jinhe Biotechnology
6.12.1 Jinhe Biotechnology Company Information
6.12.2 Jinhe Biotechnology Description and Business Overview
6.12.3 Jinhe Biotechnology Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jinhe Biotechnology Pet Antibiotic Product Portfolio
6.12.5 Jinhe Biotechnology Recent Developments/Updates
6.13 Orion Corporation
6.13.1 Orion Corporation Company Information
6.13.2 Orion Corporation Description and Business Overview
6.13.3 Orion Corporation Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Orion Corporation Pet Antibiotic Product Portfolio
6.13.5 Orion Corporation Recent Developments/Updates
6.14 Phibro Animal Health Corporation
6.14.1 Phibro Animal Health Corporation Company Information
6.14.2 Phibro Animal Health Corporation Description and Business Overview
6.14.3 Phibro Animal Health Corporation Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Phibro Animal Health Corporation Pet Antibiotic Product Portfolio
6.14.5 Phibro Animal Health Corporation Recent Developments/Updates
6.15 Vetoquinol
6.15.1 Vetoquinol Company Information
6.15.2 Vetoquinol Description and Business Overview
6.15.3 Vetoquinol Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Vetoquinol Pet Antibiotic Product Portfolio
6.15.5 Vetoquinol Recent Developments/Updates
6.16 Virbac
6.16.1 Virbac Company Information
6.16.2 Virbac Description and Business Overview
6.16.3 Virbac Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Virbac Pet Antibiotic Product Portfolio
6.16.5 Virbac Recent Developments/Updates
6.17 Zydus
6.17.1 Zydus Company Information
6.17.2 Zydus Description and Business Overview
6.17.3 Zydus Pet Antibiotic Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Zydus Pet Antibiotic Product Portfolio
6.17.5 Zydus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Antibiotic Industry Chain Analysis
7.2 Pet Antibiotic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Antibiotic Production Mode & Process Analysis
7.4 Pet Antibiotic Sales and Marketing
7.4.1 Pet Antibiotic Sales Channels
7.4.2 Pet Antibiotic Distributors
7.5 Pet Antibiotic Customer Analysis
8 Pet Antibiotic Market Dynamics
8.1 Pet Antibiotic Industry Trends
8.2 Pet Antibiotic Market Drivers
8.3 Pet Antibiotic Market Challenges
8.4 Pet Antibiotic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pet Antibiotic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pet Antibiotic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pet Antibiotic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pet Antibiotic Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pet Antibiotic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pet Antibiotic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pet Antibiotic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pet Antibiotic Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pet Antibiotic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pet Antibiotic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pet Antibiotic, Product Type & Application
 Table 12. Global Key Manufacturers of Pet Antibiotic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pet Antibiotic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Antibiotic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pet Antibiotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pet Antibiotic Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pet Antibiotic Sales Market Share by Region (2020-2025)
 Table 19. Global Pet Antibiotic Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pet Antibiotic Sales Market Share by Region (2026-2031)
 Table 21. Global Pet Antibiotic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pet Antibiotic Revenue Market Share by Region (2020-2025)
 Table 23. Global Pet Antibiotic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pet Antibiotic Revenue Market Share by Region (2026-2031)
 Table 25. North America Pet Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pet Antibiotic Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pet Antibiotic Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pet Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pet Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pet Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pet Antibiotic Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pet Antibiotic Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pet Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pet Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pet Antibiotic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pet Antibiotic Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pet Antibiotic Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pet Antibiotic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pet Antibiotic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pet Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pet Antibiotic Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pet Antibiotic Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pet Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pet Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pet Antibiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pet Antibiotic Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pet Antibiotic Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pet Antibiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pet Antibiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pet Antibiotic Sales (K Units) by Type (2020-2025)
 Table 51. Global Pet Antibiotic Sales (K Units) by Type (2026-2031)
 Table 52. Global Pet Antibiotic Sales Market Share by Type (2020-2025)
 Table 53. Global Pet Antibiotic Sales Market Share by Type (2026-2031)
 Table 54. Global Pet Antibiotic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pet Antibiotic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pet Antibiotic Revenue Market Share by Type (2020-2025)
 Table 57. Global Pet Antibiotic Revenue Market Share by Type (2026-2031)
 Table 58. Global Pet Antibiotic Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pet Antibiotic Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pet Antibiotic Sales (K Units) by Application (2020-2025)
 Table 61. Global Pet Antibiotic Sales (K Units) by Application (2026-2031)
 Table 62. Global Pet Antibiotic Sales Market Share by Application (2020-2025)
 Table 63. Global Pet Antibiotic Sales Market Share by Application (2026-2031)
 Table 64. Global Pet Antibiotic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pet Antibiotic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pet Antibiotic Revenue Market Share by Application (2020-2025)
 Table 67. Global Pet Antibiotic Revenue Market Share by Application (2026-2031)
 Table 68. Global Pet Antibiotic Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pet Antibiotic Price (US$/Unit) by Application (2026-2031)
 Table 70. Elanco Company Information
 Table 71. Elanco Description and Business Overview
 Table 72. Elanco Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Elanco Pet Antibiotic Product
 Table 74. Elanco Recent Developments/Updates
 Table 75. Zoetis Company Information
 Table 76. Zoetis Description and Business Overview
 Table 77. Zoetis Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zoetis Pet Antibiotic Product
 Table 79. Zoetis Recent Developments/Updates
 Table 80. Merck Animal Health Company Information
 Table 81. Merck Animal Health Description and Business Overview
 Table 82. Merck Animal Health Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Animal Health Pet Antibiotic Product
 Table 84. Merck Animal Health Recent Developments/Updates
 Table 85. Merial Company Information
 Table 86. Merial Description and Business Overview
 Table 87. Merial Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merial Pet Antibiotic Product
 Table 89. Merial Recent Developments/Updates
 Table 90. Bayer HealthCare Company Information
 Table 91. Bayer HealthCare Description and Business Overview
 Table 92. Bayer HealthCare Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bayer HealthCare Pet Antibiotic Product
 Table 94. Bayer HealthCare Recent Developments/Updates
 Table 95. Boehringer Ingelheim GmbH Company Information
 Table 96. Boehringer Ingelheim GmbH Description and Business Overview
 Table 97. Boehringer Ingelheim GmbH Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Boehringer Ingelheim GmbH Pet Antibiotic Product
 Table 99. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 100. Ceva Santé Animale Company Information
 Table 101. Ceva Santé Animale Description and Business Overview
 Table 102. Ceva Santé Animale Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ceva Santé Animale Pet Antibiotic Product
 Table 104. Ceva Santé Animale Recent Developments/Updates
 Table 105. Virbac Group Company Information
 Table 106. Virbac Group Description and Business Overview
 Table 107. Virbac Group Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Virbac Group Pet Antibiotic Product
 Table 109. Virbac Group Recent Developments/Updates
 Table 110. HealthforAnimals Company Information
 Table 111. HealthforAnimals Description and Business Overview
 Table 112. HealthforAnimals Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. HealthforAnimals Pet Antibiotic Product
 Table 114. HealthforAnimals Recent Developments/Updates
 Table 115. Cymedica Company Information
 Table 116. Cymedica Description and Business Overview
 Table 117. Cymedica Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Cymedica Pet Antibiotic Product
 Table 119. Cymedica Recent Developments/Updates
 Table 120. Dechra Company Information
 Table 121. Dechra Description and Business Overview
 Table 122. Dechra Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Dechra Pet Antibiotic Product
 Table 124. Dechra Recent Developments/Updates
 Table 125. Jinhe Biotechnology Company Information
 Table 126. Jinhe Biotechnology Description and Business Overview
 Table 127. Jinhe Biotechnology Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Jinhe Biotechnology Pet Antibiotic Product
 Table 129. Jinhe Biotechnology Recent Developments/Updates
 Table 130. Orion Corporation Company Information
 Table 131. Orion Corporation Description and Business Overview
 Table 132. Orion Corporation Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Orion Corporation Pet Antibiotic Product
 Table 134. Orion Corporation Recent Developments/Updates
 Table 135. Phibro Animal Health Corporation Company Information
 Table 136. Phibro Animal Health Corporation Description and Business Overview
 Table 137. Phibro Animal Health Corporation Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Phibro Animal Health Corporation Pet Antibiotic Product
 Table 139. Phibro Animal Health Corporation Recent Developments/Updates
 Table 140. Vetoquinol Company Information
 Table 141. Vetoquinol Description and Business Overview
 Table 142. Vetoquinol Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Vetoquinol Pet Antibiotic Product
 Table 144. Vetoquinol Recent Developments/Updates
 Table 145. Virbac Company Information
 Table 146. Virbac Description and Business Overview
 Table 147. Virbac Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Virbac Pet Antibiotic Product
 Table 149. Virbac Recent Developments/Updates
 Table 150. Zydus Company Information
 Table 151. Zydus Description and Business Overview
 Table 152. Zydus Pet Antibiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Zydus Pet Antibiotic Product
 Table 154. Zydus Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Pet Antibiotic Distributors List
 Table 158. Pet Antibiotic Customers List
 Table 159. Pet Antibiotic Market Trends
 Table 160. Pet Antibiotic Market Drivers
 Table 161. Pet Antibiotic Market Challenges
 Table 162. Pet Antibiotic Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pet Antibiotic
 Figure 2. Global Pet Antibiotic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pet Antibiotic Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Pet Antibiotic Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pet Antibiotic Market Share by Application: 2024 & 2031
 Figure 9. Dogs
 Figure 10. Cats
 Figure 11. Others
 Figure 12. Global Pet Antibiotic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pet Antibiotic Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pet Antibiotic Sales (2020-2031) & (K Units)
 Figure 15. Global Pet Antibiotic Average Price (US$/Unit) & (2020-2031)
 Figure 16. Pet Antibiotic Report Years Considered
 Figure 17. Pet Antibiotic Sales Share by Manufacturers in 2024
 Figure 18. Global Pet Antibiotic Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pet Antibiotic Players: Market Share by Revenue in Pet Antibiotic in 2024
 Figure 20. Pet Antibiotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pet Antibiotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pet Antibiotic Sales Market Share by Country (2020-2031)
 Figure 23. North America Pet Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 24. United States Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pet Antibiotic Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pet Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pet Antibiotic Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pet Antibiotic Revenue Market Share by Region (2020-2031)
 Figure 35. China Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Pet Antibiotic Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Pet Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Pet Antibiotic Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Pet Antibiotic Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Pet Antibiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Pet Antibiotic by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Pet Antibiotic by Type (2020-2031)
 Figure 54. Global Pet Antibiotic Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Pet Antibiotic by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Pet Antibiotic by Application (2020-2031)
 Figure 57. Global Pet Antibiotic Price (US$/Unit) by Application (2020-2031)
 Figure 58. Pet Antibiotic Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS